Objective-Circulating levels of cardiotonic steroids (CTS) are elevated in various chronic inflammatory conditions, but the role of CTS in inflammation remains largely unknown. We have previously shown that the CTS ouabain stimulates proinflammatory responses in murine macrophages. In this study, we aim to explore the mechanism how CTS induce proinflammatory responses in primary murine and human macrophages. Approach and Results-Using both murine peritoneal macrophages and human monocyte-derived macrophages, we demonstrated that ouabain activated NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells), leading to proinflammatory cytokine (eg, MCP-1 [monocyte chemotactic protein 1], TNF-α [tumor necrosis factor-α], IL-1β [interleukin-1β], and IL-6) production. By applying siRNA techniques and murine peritoneal macrophages isolated from genetically modified mice, we showed that macrophages partially deficient in Na/K-ATPase, the receptor for CTS, or fully deficient in the scavenger receptor CD36 or TLR4 (Toll-like receptor) were resistant to ouabain-induced NF-κB activation, suggesting an indispensable role of these 3 receptors in this pathway. Mechanistically, this effect of ouabain was independent of the ion transport function of the Na/K-ATPase. Instead, ouabain stimulated a signaling complex, including Na/K-ATPase, CD36, and TLR4. Subsequently, TLR4 recruited MyD88 adaptor protein for NF-κB activation. Furthermore, intraperitoneal injection of ouabain into mice specifically recruited Ly6C + CCR2 + monocyte subtypes to the peritoneal cavities, indicating that the CTS ouabain triggers inflammation in vivo. Conclusions-CTS activate NF-κB leading to proinflammatory cytokine production in primary macrophages through a signaling complex, including CD36, TLR4, and Na/K-ATPase. These findings warrant further studies on endogenous CTS in chronic inflammatory diseases, such as atherosclerosis. Visual Overview-An online visual overview is available for this article. 
N F-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a transcription factor expressed in most cell types. It mediates expression of many genes involved in inflammation and is considered a master regulator of immunity. 1 In macrophages, the NF-κB pathway is activated in response to microbial infection when pathogen-associated molecular patterns are recognized by pattern recognition receptors, particularly of the TLR (Toll-like receptor) family. 2 This leads to a portfolio of proinflammatory responses, including reactive oxygen species generation, proinflammatory cytokine production, and attraction of more immune cells to the infection sites.
1 NF-κB can also be activated in the absence of pathogens, and abnormal activation/ termination of this pathway is involved in various chronic inflammatory diseases, including atherosclerosis, 3 rheumatoid arthritis, 4 and diabetes mellitus. 5 The mechanisms underlying NF-κB activation in these settings remain incompletely understood.
Cardiotonic steroids (CTS), such as ouabain and digitalis, are naturally occurring plant alkaloids with biological activities based on their ability to bind the α subunit of the plasma membrane ion channel, Na/K-ATPase (NKA), and thereby modulate its transport function. 6 NKA actively transports Na + and K + across the plasma membrane using energy from ATP 6 and is essential for normal cellular hemostasis. The NKA modulating activity of CTS has been exploited pharmacologically for decades related to its positive cardiac inotropic effect. The therapeutic window is narrow, however, and CTS have also been used as potent neurotoxins. CTS have been shown to stimulate signaling cascades through NKA at much lower concentrations than needed to impact ion transport. [7] [8] [9] [10] [11] [12] These signaling functions are mediated by localized intracellular activation of Srcfamily kinases and are independent of ion transport; because of the differences in dose response, it is possible to activate NKA-mediated Src-family kinases signaling without altering Na/K homeostasis. This may have pathological significance in humans as an analog of ouabain has been detected in human plasma, 13 and levels of the so-called endogenous CTS are elevated in diseases associated with chronic inflammation. [14] [15] [16] [17] We previously showed that NKA interacts structurally and functionally in macrophages with the type 2 scavenger receptor CD36, and that this interaction is enhanced by oxidized low-density lipoprotein (oxLDL). OxLDL/CD36-mediated proinflammatory, proatherogenic signaling in macrophages was diminished by knocking down NKA expression, and NKA knockdown in bone marrow cells partially protected mice from diet-induced atherosclerosis. 18 In this study, we used human monocyte-derived macrophages (HMDM) to demonstrate that the CTS ouabain activates the NF-κB pathway leading to proinflammatory cytokine production. Mechanistically, ouabain at concentrations that did not impact Na/K transport enhanced NKA/CD36 complex formation and led to recruitment of TLR4 and MyD88 to the signaling complex. Moreover, injection of ouabain into mice induced an inflammatory response in vivo that specifically attracted monocytes/ macrophages to the peritoneal cavity. This study linking CTS to NF-κB activation through NKA and CD36 signaling sheds light on a potential role of endogenous CTS in chronic inflammatory disorders and may also explain some of the unexpected negative clinical outcomes associated with chronic CTS use in humans.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Ouabain Activates NF-κB and Stimulates Proinflammatory Cytokine Production in Human Macrophages
HMDM incubated with the CTS ouabain exhibited a rapid and sustained decrement in IκB-α levels, as shown by Western blot ( Figure 1A ). The effect was dose dependent with significant decreases seen at concentrations as low as 5 nmol/L and maximum effect seen at 25 nmol/L ( Figure 1B ). Lipopolysaccharide (LPS) contamination in ouabain preparations could be responsible for NF-κB activation, but LPS was not detected in any samples using an assay sensitive to 1 to 10 pg/mL ( Figure IA in the online-only Data Supplement), and low doses of LPS (1 pg/mL) did not stimulate IκB-α degradation in our system ( Figure IB in the online-only Data Supplement). Because NF-κB translocates to the nucleus after IκB-α degradation, we also performed immunofluorescence staining with anti-NF-κB antibody and showed directly that ouabain-treated cells had increased nuclear localization compared with control ( Figure 2A ) with ≈2× more nuclei staining for NF-κB ( Figure 2B ; P<0.0001). To test NF-κB transcriptional activity directly, we used a commercially available reporter system (THP1-Dual cells 19 ) and found that 25 nmol/L ouabain increased NF-κB-dependent transcriptional activity by up 3-fold ( Figure 2C ; P<0.0001). Consistent with the well-known role of NF-κB in regulating proinflammatory genes, we used quantitative real time-polymerase chain reaction to demonstrate that ouabain significantly increased expression of MCP-1 (monocyte chemotactic protein 1), TNF-α (tumor necrosis factor-α), PTGS2 (prostaglandin endoperoxide synthase 2), CCL5 (chemokine (CC motif) ligand 5), IL-6 (interleukin-6), IL-1β, ICAM1 (intercellular adhesion molecule 1), CXCL9 (chemokine (CXC motif) ligand), and CXCL10 in HMDM ( Figure 3A) . Expression of the anti-inflammatory gene IL-27 was decreased by 90% after ouabain treatment ( Figure 3B ; P<0.0001), whereas expression of IL-10, another anti-inflammatory gene, was minimally impacted. To confirm the mRNA results, we measured cytokine protein levels in postculture media by ELISA and found that ouabain treatment also led to significantly increased levels of MCP-1, TNF-α, IL-1β, and IL-6 ( Figure 3C ; P<0.0001). Cytokine expression was fully abolished by a specific pharmacological IκB kinase inhibitor, Wedelolactone ( Figure 3C ). These data indicate that ouabain stimulated human macrophage proinflammatory cytokine production through the NF-κB pathway.
Ouabain Activation of NF-κB in HMDM Is Not Because of Ion Transport and Requires Both NKA and CD36
Previous studies showed that ouabain modulation of Na/K transport mobilized intracellular Ca 2+ in renal proximal tubule cells which resulted in NF-κB activation.
20 Surprisingly, ouabain at concentrations ≤0.1 mmol/L did not affect intracellular Ca 2+ levels in HMDM as detected with the fluorescent Ca 2+ indicator Fluo-4 AM ( Figure IC in the online-only Data Supplement). Moreover, whereas treatment with the Ca 2+ ionophore ionomycin led, as expected, to increased intracellular Ca 2+ levels, the sodium ionophore monensin did not, suggesting that increasing intracellular Na + levels are not sufficient to raise cytosolic Ca 2+ levels in human macrophages ( Figure IC in the online-only Data Supplement). Monensin did not induce significant degradation of IκB-α ( Figure ID in the online-only Data Supplement). These data strongly suggest that the effect of ouabain on NF-κB activation in HMDM was not because of ion shifts and subsequent Ca 2+ mobilization. To determine the role of NKA signaling in ouabain-induced NF-κB activation, we used siRNA to knock down expression of the NKA α1 subunit by 80% in HMDM ( Figure IIA −/− mice were treated with 100 μmol/L ouabain or 100 ng/mL lipopolysaccharide (LPS) for 1 h, and cell lysates were immunoblotted for IκB-α and β-actin. Representative Western blot images were shown. Quantified data from 3 separate experiments were combined and shown below the images. *P<0.05, ***P<0.001, ****P<0.0001. C, Left, Peritoneal macrophages were treated with 50 μmol/L ouabain for 24 h. MCP-1 (monocyte chemotactic protein 1) levels in the postculture medium were determined by ELISA assay. Combined data from 6 separate experiments were shown. Right, siRNA-transfected THP-1 Dual cells were treated with ouabain for 24 h. Culture medium was collected for NF-κB reporter assay. Data from 8 separate experiments were combined and shown. D, CD36 immunoprecipitates from HMDMs were immunoblotted for NKA α1 and CD36. Representative blot images were shown, and quantified data were combined from 4 separate experiments and shown in the bar graph.
ouabain-induced IκB-α degradation ( Figure 4A ). To confirm these findings, we also studied peritoneal macrophages isolated from cd36 null and atp1a1 heterozygous null mice (NKA α1 +/− ). The latter express 60% less NKA α1 in peritoneal macrophages compared with cells from wild-type mice. 21 Although macrophages from NKA α1 +/− and CD36 −/− mice responded normally to LPS in terms of IκB-α degradation, they did not respond to ouabain ( Figure 4B ). Ouabain-induced MCP-1 production was also abolished in NKA α1 +/− and CD36 −/− macrophages ( Figure 4C, left) . Furthermore, siRNA-mediated knockdown of either NKA α1 or CD36 in THP1-Dual cells ( Figure III in the online-only Data Supplement) prevented ouabain-induced NF-κB transcriptional activity ( Figure 4C, right) . These data indicate that both NKA α1 and CD36 are required for ouabaininduced NF-κB activation.
These observations prompted us to hypothesize that ouabain-induced proinflammatory signaling in macrophages was mediated by NKA α1/CD36 interactions. Using coimmunoprecipitation, we showed ( Figure 4D ) that anti-CD36 immunoprecipitates from ouabain-treated cells contained ≈2-fold more NKA α1 than from control cells, suggesting that ouabain stimulates the formation of NKA/CD36 signaling complexes.
The NKA/CD36 Signaling Complex Recruits TLR4, Which Is Necessary for the Ouabain Effects
To explore signaling downstream of NKA/CD36 in the ouabain response, we tested the role of TLR4, which is known to interact with CD36 in oxLDL-mediated NF-κB activation in macrophages. 22 Immunoprecipitation with anti-NKA α1 from HMDM lysates revealed that TLR4 coprecipitated with NKA α1 under basal conditions and that treatment with ouabain resulted in ≈2-fold more TLR4 in the precipitates ( Figure 5A) . Similarly, immunoprecipitation with anti-CD36 also showed ≈2-fold more TLR4 in the precipitates from ouabain-treated cells ( Figure 5B ). In addition, ouabain failed to induce IκB-α degradation ( Figure 4B ) and MCP-1 production ( Figure 4C , left) in tlr4 null (TLR4 −/− ) macrophages, indicating that TLR4 is required in this pathway. Furthermore, Figure 5C shows that ouabain stimulated recruitment of the adaptor protein MyD88 to TLR4 immunoprecipitates, consistent with activation of the TLR4 pathway. Using siRNA targeting MyD88 ( Figure III in the online-only Data Supplement), we found that knockdown of MyD88 blocked ouabain-induced NF-κB activity ( Figure 4C, right) . CLI-095, a small molecular weight chemical inhibitor that specifically binds to the cytosolic domain of TLR4 and blocks recruitment of MyD88, 23, 24 significantly decreased MCP-1 levels in the postculture media from ouabain-treated HMDM ( Figure 5D ; P<0.001). In sum, these results indicate that the CTS ouabain activates NF-κB in HMDM through a TLR4/MyD88 pathway.
Ouabain Elicits NKA/CD36-Dependent Inflammation In Vivo
To determine the in vivo relevance of these findings, we injected mice intraperitoneally with ouabain and 4 and 24 hours later collected peritoneal cells by lavage with phosphate-buffered saline. Cellular content was quantified and analyzed by flow cytometry using a panel of cell-specific antibodies. The gating strategy for all genotypes and quantification of different white blood cell types is shown in Figure IV in the online-only Data Supplement. Figure 6A shows that compared with phosphatebuffered saline (vehicle)-injected mice, mice injected with ouabain for 4 hours showed ≈60% increase in CD11c + cells were most likely monocytes attracted from the circulation instead of local proliferated macrophages. Consistently, we detected elevated levels of MCP-1 in peritoneal fluid 4 hours after ouabain injection ( Figure 6B ). Twenty-four hours after ouabain injection, we detected a further increase in the monocytes/macrophage population ( Figure 6A ; Figure VA in the online-only Data Supplement), whereas neutrophils dropped to the basal level. In addition, we observed a 50% decrease in expression levels of IκB-α in peritoneal cells after ouabain injection, indicating activation of NF-κB pathway by ouabain in vivo ( Figure VB in the online-only Data Supplement). There are 2 major subsets of mouse monocytes based on differential expression of inflammatory monocyte marker, Ly6C (Ly6C + subtype and Ly6C − subtype). 25 Subtype Figure 6C ). This is consistent with in vitro and in vivo data that ouabain stimulated MCP-1 production and secretion (Figures 3 and 6) , as CCR2 is the receptor for MCP-1 and typically highly expressed on Ly6C + monocyte surface. 26 Contrary to monocytes, the levels of CD4 Figure 6D ). These in vivo data are consistent with the in vitro data that ouabain proinflammatory signaling was mediated by a NKA/CD36 complex ( Figure 4 ).
Discussion
Detectable levels of circulating endogenous CTS are well documented in humans, 13, 27 and elevated levels into the nanomolar range have been reported in various diseases, including hypertension, 14, 15 congestive heart failure, 16, 28 and type 2 diabetes mellitus, 17 all of which are associated with the chronic inflammatory disease atherosclerosis. However, the effect of CTS on immune cell functions and the underlying molecular mechanisms remain poorly understood. In this study, we discovered that the CTS ouabain induced assembly of a multiprotein receptor complex in macrophages made up of CD36, TLR4, and NKA, and that this triggered activation of NF-κB. In addition, other CTS compounds, including digoxin and marinobufagenin, showed similar NF-κB-stimulating effects Previous studies reported that ouabain at pharmacological doses activated NF-κB in rat renal proximal tubular cells via a mechanism dependent on mobilization of intracellular Ca 2+ , presumably related to the ion transport functions of NKA. 20 By inhibiting NKA pump activity, CTS treatment leads to intracellular Na + elevation, and then via reversed Na/ Ca exchange activity, 27 Na + moves out of the cells in exchange for Ca 2+ . NKA was also shown to interact with the inositol trisphosphate receptor stimulating Ca 2+ release from intracellular stores 29, 30 in a ouabain-dependent manner. Our studies, however, suggest that the mechanism of NF-κB activation in macrophages by CTS is different. The dose of ouabain used in our studies (25 nmol/L) did not lead to elevation of intracellular Ca 2+ levels, and doses 4000-fold higher (0.1 mmol/L) that inhibit NKA pumping activity did not increase intracellular Ca 2+ levels in HMDM. Moreover, the Na + ionophore monensin neither increased intracellular Ca 2+ levels nor activated NF-κB. Knocking down NKA α1 expression using siRNA abolished the ouabain effect, rather than promoting it, which is also consistent with a mechanism independent of NKA transport inhibition and Ca 2+ signaling. Our data reveal a novel mechanism by which ouabain stimulates the formation of a multiprotein complex, including NKA, CD36, and TLR4, which then triggers NF-κB activation. An important question is how CTS stimulate assembly of the CD36/NKA/TLR4 complex. Both the NKA ligand ouabain and the CD36 ligand oxLDL are capable of enhancing the NKA/CD36 interaction in macrophages. 18, 21 In addition, both NKA and CD36 are known to be concentrated in specific cholesterol-rich membrane microdomains, 31, 32 placing the 2 plasma membrane receptors in close proximity. It is thus possible that their specific ligands induce conformational changes that facilitate protein-protein interactions between the 2 receptors. This model explains why CD36 −/− macrophages showed much lower response to ouabain because CD36 plays a role as an essential adaptor protein linking TLR4 signaling to CTS.
NF-κB is a master regulator of inflammation, 1 and its signaling is implicated in all stages of atherosclerosis. 3 In agreement with a proatherogenic role of CTS, we found that CTS activation of NF-κB led to proinflammatory cytokine production and secretion, including MCP-1, TNF-α, IL-1β, and IL-6, all of which are highly proatherogenic. [33] [34] [35] [36] We reported previously that plasma CTS levels were significantly elevated in apoe null mice fed a high-fat diet, 18 a widely used atherosclerotic animal model. 37 Furthermore, we recently showed that downregulation of the CTS receptor NKA in apoe null mice significantly reduced macrophage recruitment to atherosclerotic plaque and protected mice from diet-induced atherosclerosis. Thus, our studies suggest that elevated endogenous CTS, by stimulating chronic NKA signaling and NF-κB pathway activation, could promote chronic inflammation and thereby promote atherosclerosis.
In macrophages, CD36 cooperates with TLR4 to mediate inflammatory responses to exogenous and endogenous danger signals, including proatherogenic oxLDL. 22 Our findings that CTS, similarly to oxLDL, also stimulated assembly of a CD36/TLR4 complex leading to NF-κB activation suggest that CTS may represent a previously unrecognized group of endogenous danger signals that mediate sterile inflammation in vivo. On the other hand, we have reported previously on the proatherogenic functions of CD36 such as uptake of oxLDL leading to foam cell formation, 38 inhibition of cell migration, 39 and reactive oxygen species generation. 39, 40 It will be of high interest to test whether CTS/NKA signaling also promotes these CD36-mediated functions.
Taken together, we have defined a novel mechanistic connection between the proatherogenic innate immune response and CTS/NKA signaling. Because CTS antagonists, such as pNaKitde 41 and rostafuroxin, 42 have been developed, it will be interesting to test whether they are effective against atherosclerosis in vivo and therefore provide a novel therapeutic strategy. Finally, our findings may also provide a mechanistic basis for recent clinical reports of increased mortality rates in patients taking digoxin in the setting of chronic heart diseases. [43] [44] [45] 
